학술논문

The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study
Document Type
Article
Source
In: International Journal of Clinical Oncology. (International Journal of Clinical Oncology, March 2024, 29(3):258-265)
Subject
Language
English
ISSN
14377772
13419625